HELIX, INC. for HELIX, INC.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report | Apr 3, 2023 | $40,000 | Replaced |
| 1st Quarter - Amendment (this page) | Aug 3, 2023 | $120,000 | Yes |
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Viral sequencing derived from blood and spital, viral surveillance and COVID-19 not limited to issues in US H1425 Senate Ratification of Pandemic World Health Organization Agreements, planning for FY24 budget, and Pandemic All Hazards Preparedness Reauthorization. Issues related to biomarker testing, hereditary cancers, and pharmacogenomics including US S708 Medicaid Coverage for Major Depressive Disorders.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KELLI ARTHUR HYKES | — |
Medical/Disease Research/Clinical Labs MED
COVID-19, other respiratory pathogen sequencing, including a comprehensive early warning network and countermeasure development in relation to Pandemic All Hazards Preparedness Act Reauthorization, express congressional authorization for FDA regulation of lab developed tests.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KELLI ARTHUR HYKES New | — |
Budget/Appropriations BUD
Funding for viral sequencing (AMD, ASPR), data modernization, Center for Forecasting and Analytics and other non-specific programs to enhance interdepartmental communication on viral surveillance efforts, including considerations in the End the Threat of Default Act US-H415
| Lobbyist | Covered position, as disclosed |
|---|---|
| KELLI ARTHUR HYKES | — |
Science/Technology SCI
Viral surveillance and viral sequencing, development of medical countermeasure for pathogens of pandemic potential
| Lobbyist | Covered position, as disclosed |
|---|---|
| KELLI ARTHUR HYKES | — |
Defense DEF
Biosecurity efforts around viral surveillance and sequencing for known and unknown pathogens, intergovernmental cooperation on pathogens of pandemic potential
| Lobbyist | Covered position, as disclosed |
|---|---|
| KELLI ARTHUR HYKES | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.